Literature DB >> 19631731

Mild cerebral hypoxia-ischemia produces a sub-acute transient inflammatory response that is less selective and prolonged after a substantial insult.

Min Qiao1, Shuzhen Meng, Tadeusz Foniok, Ursula I Tuor.   

Abstract

Cerebral ischemia initiates various injurious processes including neuroinflammatory responses such as activation of microglia and increases in cytokine and nitric oxide release. Evidence primarily from in vitro studies, indicates that neuroinflammatory effects can be either beneficial or harmful, possibly related to stimulus strength. We investigated using in vivo models, the effect of a mild or substantial cerebral hypoxia-ischemia on: cerebral microglial/macrophage activation (ED1), pro-inflammatory cytokines (tumor necrosis factor-alpha), nitrosative stress (nitrotyrosine) and permanent brain damage. A mild insult produced a transient (1-2 days post) increase in activated microglia/macrophages within subcortical white and not gray matter but transiently increased cytokine or nitrotyrosine expression in cortex and not white matter. There was also prolonged scattered cell death in cortex and white matter over weeks along with loss of myelin/axons and cortical atrophy at 4 weeks post-insult. In contrast, a substantial insult produced white and gray matter necrosis, cyst formation and atrophy, along with increases in tumor necrosis factor and nitrotyrosine staining within both white and gray matter starting at 1-2 days post-insult. Microglial/macrophage staining was increased starting at 1-week post a substantial insult and remained elevated for weeks thereafter. Thus, a transient neuroinflammatory response occurs following a mild insult whereas prolonged scattered cell death occurs for weeks, particularly in white matter. Insult severity also affects the progression of the neuroinflammatory response, which is prolonged after a substantial insult. Effective therapy will need to be customized for insult severity and timing; and, monitoring the injury processes with imaging or biomarkers may help guide treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631731     DOI: 10.1016/j.ijdevneu.2009.07.004

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  7 in total

1.  New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats.

Authors:  Xiaoping Wang; Chao Wang; Yan Yang; Jingman Ni
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

2.  Decreased cortical thickness in central hypoventilation syndrome.

Authors:  Paul M Macey; Ammar S Moiyadi; Rajesh Kumar; Mary A Woo; Ronald M Harper
Journal:  Cereb Cortex       Date:  2011-09-30       Impact factor: 5.357

3.  Ischemia as a possible effect of increased intra-abdominal pressure on central nervous system cytokines, lactate and perfusion pressures.

Authors:  Athanasios Marinis; Eriphili Argyra; Pavlos Lykoudis; Paraskevas Brestas; Kassiani Theodoraki; Georgios Polymeneas; Efstathios Boviatsis; Dionysios Voros
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

4.  Spatio-temporal course of macrophage-like cell accumulation after experimental embolic stroke depending on treatment with tissue plasminogen activator and its combination with hyperbaric oxygenation.

Authors:  D Michalski; M Heindl; J Kacza; F Laignel; L Küppers-Tiedt; D Schneider; J Grosche; J Boltze; M Löhr; C Hobohm; W Härtig
Journal:  Eur J Histochem       Date:  2012-05-09       Impact factor: 3.188

5.  Cellular correlates of longitudinal diffusion tensor imaging of axonal degeneration following hypoxic-ischemic cerebral infarction in neonatal rats.

Authors:  Ursula I Tuor; Melissa Morgunov; Manasi Sule; Min Qiao; Darren Clark; David Rushforth; Tadeusz Foniok; Adam Kirton
Journal:  Neuroimage Clin       Date:  2014-08-07       Impact factor: 4.881

6.  Recurrent mild cerebral ischemia: enhanced brain injury following acute compared to subacute recurrence in the rat.

Authors:  Ursula I Tuor; Zonghang Zhao; Philip A Barber; Min Qiao
Journal:  BMC Neurosci       Date:  2016-05-26       Impact factor: 3.288

7.  Protection against recurrent stroke with resveratrol: endothelial protection.

Authors:  Darren Clark; Ursula I Tuor; Roger Thompson; Adam Institoris; Angela Kulynych; Xu Zhang; David W Kinniburgh; Ferenc Bari; David W Busija; Philip A Barber
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.